Skip to main content
Equibles

MORGAN STANLEY

Position in MOLN — Molecular Partners AG

CIK 895421 NEW YORK, NY
Back to MOLN Full portfolio

Position in MOLN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,420
-$36 QoQ
Shares Held
367
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 5 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MOLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. MOLN ranks #463 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in MOLN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,420 367
2026-03-31 $1,456 367
2025-12-31 $1,599 367
2025-09-30 $1,361 367
2025-06-30 $1,401 367
2025-03-31 $1,423 367
2024-12-31 $1,742 367
2024-09-30 $2,542 500
2024-06-30 $2,653 367
2024-03-31 $1,541 367
2023-12-31 $1,534 367
2023-09-30 $1,519 367
2023-06-30 $2,282 367
2023-03-31 $2,215 367
2022-12-31 $2,403 367
2022-09-30 $2,455 367
2022-06-30 $2,488 367
2022-03-31 $7,541 367
2021-06-30 $24,608 1,201